NovoCure Ltd.
(NASDAQ : NVCR)

( )
NVCR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. 0.99%545.951.0%$723.18m
MDTMedtronic Plc 2.03%90.470.6%$692.05m
DHRDanaher Corp. 0.69%256.930.7%$681.40m
ABTAbbott Laboratories 3.03%109.430.8%$608.35m
ISRGIntuitive Surgical, Inc. 2.53%209.670.8%$454.37m
BSXBoston Scientific Corp. 3.25%38.141.0%$339.98m
ALGNAlign Technology, Inc. 3.04%258.756.4%$321.15m
BDXBecton, Dickinson & Co. 3.41%250.801.0%$275.10m
EWEdwards Lifesciences Corp. 3.90%97.270.4%$268.56m
SYKStryker Corp. 2.34%204.741.3%$264.86m
IDXXIDEXX Laboratories, Inc. 1.65%361.483.8%$242.08m
AAgilent Technologies, Inc. 2.07%121.051.7%$225.19m
BAXBaxter International, Inc. 2.61%66.781.8%$207.19m
SWAVShockwave Medical, Inc. 6.27%197.690.0%$175.43m
DXCMDexCom, Inc. 3.27%77.671.9%$172.64m

Company Profile

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.